The Association of Substitutions in the Hepatitis C Virus Subtype 1b Core Gene and IL28B Polymorphisms With the Response to Peg-IFNα-2a/RBV Combination Therapy in Azerbaijani Patients

BACKGROUND: The hepatitis C virus (HCV) infection has been identified as a leading cause of progressive liver diseases worldwide. Despite new treatment strategies, pegylated interferon alfa-2a (Peg-IFNα-2a), in combination with ribavirin (RBV), still represents the gold standard of therapy for hepat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Hepat Mon
Main Authors: Bokharaei-Salim, Farah, Salehi-Vaziri, Mostafa, Sadeghi, Farzin, Esghaei, Maryam, Monavari, Seyed Hamidreza, Alavian, Seyed Moayed, Fakhim, Shahin, Keyvani, Hossein
Formato: Artigo
Idioma:Inglês
Publicado em: Kowsar 2016
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4908614/
https://ncbi.nlm.nih.gov/pubmed/27313635
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5812/hepatmon.35597
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados